friends of FSH Research


The Beginnings of something new in FSHD Research?

— June 1, 2009

Research on the cause and treatment of facioscapulohumeral muscular dystrophy (FSHD) might be entering a new, and hopefully better, era. For many years FSHD has been a difficult disease for medical researchers to study. In most genetic diseases, a gene with some known function is mutated and no longer performs its normal biological role. To find a treatment for such a disease, the medical researcher needs to identify therapeutic interventions that will compensate for the mutant gene.

Evaluating the stem cell hypothesis for FSHD

— August 8, 2008

Dr. Michael Kyba: Evaluating the stem cell hypothesis for FSHD

— August 1, 2008

Dr. Kyba will insert D4Z4 repeats into the mouse genome in ES at a site on the X-chromosome, known to enable tissue-specific expression of transgenes, and to tolerate dominant lethal genes. He will study whether the presence of these repeats affects differentiation of the ES cells, and will produce mice bearing D4Z4 repeats, as a potential animal model for FSHD.

FSHD Grant Awarded to UW Researcher

— July 19, 2008

Friends of FSH Research in collaboration with the MDA fund a two-year grant for Dr. Joel Chamberlain.

Five-Year NIH Grant for FSH Research

— April 15, 2008

$6.3 Million Dollar Grant for FSH Research — The Pathogenesis of FSHD.